Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew R Allen

Showing results (171-180 of 221) with videos related to

Pageof 23
Sort By:
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 20, 2019
Effect of Advanced Glycation End-Products (AGE) Lowering Drug ALT-711 on Biochemical, Vascular, and Bone Parameters in a Rat Model of CKD-MBDNeal X Chen, Shruthi Srinivasan, Kalisha O'Neill, et al.
JCI Insight|March 5, 2019
Increased FGF23 protects against detrimental cardio-renal consequences during elevated blood phosphate in CKDErica L Clinkenbeard, Megan L Noonan, Joseph C Thomas, et al.
Bioorganic & Medicinal Chemistry|January 23, 2016
Structural features underlying raloxifene's biophysical interaction with bone matrixNicoletta Bivi, Haitao Hu, Balagopalakrishna Chavali, et al.
Bioorganic & Medicinal Chemistry|August 22, 2016
Corrigendum to "Structural features underlying raloxifene's biophysical interaction with bone matrix" [Bioorg. Med. Chem. 24 (2016) 759-767]Nicoletta Bivi, Haitao Hu, Balagopalakrishna Chavali, et al.
Bone|April 4, 2024
Combining raloxifene and mechanical loading improves bone composition and mechanical properties in a murine model of chronic kidney disease (CKD)Rachel K Surowiec, Olivia N Reul, Nusaiba N Chowdhury, et al.
Plos One|August 4, 2016
Skeletal Muscle Regeneration and Oxidative Stress Are Altered in Chronic Kidney DiseaseKeith G Avin, Neal X Chen, Jason M Organ, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 8, 2015
Reduced skeletal muscle function is associated with decreased fiber cross-sectional area in the Cy/+ rat model of progressive kidney diseaseJason M Organ, Andrew Srisuwananukorn, Paige Price, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 9, 2010
PTH receptor signaling in osteocytes governs periosteal bone formation and intracortical remodelingYumie Rhee, Matthew R Allen, Keith Condon, et al.
Bone|January 29, 2014
Bone cell-independent benefits of raloxifene on the skeleton: a novel mechanism for improving bone material propertiesMaxime A Gallant, Drew M Brown, Max Hammond, et al.
Bone Reports|February 5, 2020
6'-Methoxy Raloxifene-analog enhances mouse bone properties with reduced estrogen receptor bindingKatherine M Powell, Alexa P Brown, Cayla G Skaggs, et al.
Pageof 23

Showing results (171-180 of 221) with videos related to

Sort By:
Pageof 23
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 20, 2019
Effect of Advanced Glycation End-Products (AGE) Lowering Drug ALT-711 on Biochemical, Vascular, and Bone Parameters in a Rat Model of CKD-MBDNeal X Chen, Shruthi Srinivasan, Kalisha O'Neill, et al.
JCI Insight|March 5, 2019
Increased FGF23 protects against detrimental cardio-renal consequences during elevated blood phosphate in CKDErica L Clinkenbeard, Megan L Noonan, Joseph C Thomas, et al.
Bioorganic & Medicinal Chemistry|January 23, 2016
Structural features underlying raloxifene's biophysical interaction with bone matrixNicoletta Bivi, Haitao Hu, Balagopalakrishna Chavali, et al.
Bioorganic & Medicinal Chemistry|August 22, 2016
Corrigendum to "Structural features underlying raloxifene's biophysical interaction with bone matrix" [Bioorg. Med. Chem. 24 (2016) 759-767]Nicoletta Bivi, Haitao Hu, Balagopalakrishna Chavali, et al.
Bone|April 4, 2024
Combining raloxifene and mechanical loading improves bone composition and mechanical properties in a murine model of chronic kidney disease (CKD)Rachel K Surowiec, Olivia N Reul, Nusaiba N Chowdhury, et al.
Plos One|August 4, 2016
Skeletal Muscle Regeneration and Oxidative Stress Are Altered in Chronic Kidney DiseaseKeith G Avin, Neal X Chen, Jason M Organ, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 8, 2015
Reduced skeletal muscle function is associated with decreased fiber cross-sectional area in the Cy/+ rat model of progressive kidney diseaseJason M Organ, Andrew Srisuwananukorn, Paige Price, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 9, 2010
PTH receptor signaling in osteocytes governs periosteal bone formation and intracortical remodelingYumie Rhee, Matthew R Allen, Keith Condon, et al.
Bone|January 29, 2014
Bone cell-independent benefits of raloxifene on the skeleton: a novel mechanism for improving bone material propertiesMaxime A Gallant, Drew M Brown, Max Hammond, et al.
Bone Reports|February 5, 2020
6'-Methoxy Raloxifene-analog enhances mouse bone properties with reduced estrogen receptor bindingKatherine M Powell, Alexa P Brown, Cayla G Skaggs, et al.
Pageof 23